Sunday 3 November 2013

Solanezumab, Eli Lilly’s anti-beta-amyloid monoclonal antibody for Alzheimer’s disease « New Drug Approvals

Solanezumab, Eli Lilly’s anti-beta-amyloid monoclonal antibody for Alzheimer’s disease « New Drug Approvals:

'via Blog this'

No comments:

Post a Comment